|
2025 Conference Publication The Molecular Mechanism for Reversed Dopamine D2 Receptor Cellular Output and Defecation Control, Enabled by Constitutive Ghrelin Receptor ActivityFurness, Sebastian, Dehkhoda, Farhad, Ringuet, Mitchell, Nowell, Cameron, Misganaw, Desye, Xu, Zheng, McDougall, Stuart and Furness, John (2025). The Molecular Mechanism for Reversed Dopamine D2 Receptor Cellular Output and Defecation Control, Enabled by Constitutive Ghrelin Receptor Activity. 2025 ASBMB Annual Meeting, Brisbane, QLD Australia, 29 September - 1 October 2025. Bethesda, MD United States: American Society for Biochemistry and Molecular Biology. doi: 10.1016/j.jbc.2025.110108 |
|
2025 Conference Publication The molecular mechanism for reversed dopamine D2 receptor cellular output and defecation control, enabled by constitutive ghrelin receptor activityDhekhoda, Farhad, Furness, John and Furness, Sebastian (2025). The molecular mechanism for reversed dopamine D2 receptor cellular output and defecation control, enabled by constitutive ghrelin receptor activity. American Physiology Summit, Baltimore Md, Apr 24-27, 2025. Rockville: AMER PHYSIOLOGICAL SOC. doi: 10.1152/physiol.2025.40.S1.2010 |
|
2025 Conference Publication CCK-58 and CCK-8 are non-equivalent in signal transduction at human cholecystokinin 1 receptor (CCK1R) in transfected cell linesXing, Jingjing, Dehkhoda, Farhad and Furness, Sebastian (2025). CCK-58 and CCK-8 are non-equivalent in signal transduction at human cholecystokinin 1 receptor (CCK1R) in transfected cell lines. ASPET 2025, Portland, OR, United States, 3-6 April 2025. Rockville, MD, United States: American Society for Pharmacology and Experimental Therapeutics. doi: 10.1016/j.jpet.2025.103430 |
|
2023 Conference Publication Modulation of dopamine's effect at dopamine 2 receptors (D2R) mediated by association with the ghrelin receptor, GHSRFurness, John, Dehkhoda, Farhad, Whitfield, Emily, Fothergill, Linda, Misgenaw, Desye, Ringuet, Mitchell and Furness, Sebastian (2023). Modulation of dopamine's effect at dopamine 2 receptors (D2R) mediated by association with the ghrelin receptor, GHSR. American Physiology Summit 2023, Long Beach, CA, United States, 20-23 April 2023. Rockville, MD, United States: American Physiological Society. doi: 10.1152/physiol.2023.38.s1.5731818 |
|
2020 Conference Publication Evidence that Dopamine is the Physiological Agonist of Spinal Gherlin Receptors and Acts Through Heteromeric Dopamine D2/ Ghrelin ReceptorsFurness, Sebastian, Pustovit, Ruslan, Ringuet, Mitchell, Molero, Juan, Fothergill, Linda and Furness, John (2020). Evidence that Dopamine is the Physiological Agonist of Spinal Gherlin Receptors and Acts Through Heteromeric Dopamine D2/ Ghrelin Receptors. Annual Meeting on Experimental Biology, San Diego Ca, Apr 04-07, 2020. HOBOKEN: WILEY. doi: 10.1096/fasebj.2020.34.s1.04678 |
|
2013 Conference Publication Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) functionKoole, Cassandra, Pabreja, Kavita, Savage, Emilia E., Wootten, Denise, Furness, Sebastian G. B., Miller, Laurence J., Christopoulos, Arthur and Sexton, Patrick M. (2013). Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function. Biochemical Society Meeting, London, United Kingdom: Portland Press. doi: 10.1042/BST20120236 |
|
2012 Conference Publication Expression, function and targeting of calcitonin receptor in glioma cells of the brain tumour glioblastoma multiforme (GBM)Furness, S. (2012). Expression, function and targeting of calcitonin receptor in glioma cells of the brain tumour glioblastoma multiforme (GBM). 22nd International-Union-of-Biochemistry-and-Molecular-Biology (IUBMB) Congress/37th Federation-of-European-Biochemical-Societies (FEBS) Congress, Seville Spain, Sep 04-09, 2012. HOBOKEN: WILEY. |
